Gary W. Ashley

4.7k total citations
93 papers, 3.9k citations indexed

About

Gary W. Ashley is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Gary W. Ashley has authored 93 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 20 papers in Organic Chemistry and 18 papers in Pharmacology. Recurrent topics in Gary W. Ashley's work include Microbial Natural Products and Biosynthesis (16 papers), Cancer therapeutics and mechanisms (12 papers) and Enzyme Structure and Function (9 papers). Gary W. Ashley is often cited by papers focused on Microbial Natural Products and Biosynthesis (16 papers), Cancer therapeutics and mechanisms (12 papers) and Enzyme Structure and Function (9 papers). Gary W. Ashley collaborates with scholars based in United States, United Kingdom and Japan. Gary W. Ashley's co-authors include Daniel V. Santi, Ralph R. Reid, Robert McDaniel, Jeff Henise, C. Richard Hutchinson, Shaun D. Fontaine, Mary C. Betlach, Hong Fu, G.T. Burstein and Eric L. Schneider and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Gary W. Ashley

91 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary W. Ashley United States 33 2.3k 1.1k 837 351 338 93 3.9k
Francesco Nicotra Italy 37 2.6k 1.1× 473 0.4× 2.3k 2.7× 736 2.1× 246 0.7× 215 5.3k
Enea Menegatti Italy 36 2.0k 0.9× 151 0.1× 510 0.6× 256 0.7× 286 0.8× 166 4.2k
Jörg Rademann Germany 38 2.7k 1.2× 329 0.3× 2.1k 2.5× 189 0.5× 354 1.0× 169 4.5k
Keykavous Parang United States 39 3.0k 1.3× 236 0.2× 1.8k 2.2× 255 0.7× 504 1.5× 234 5.4k
Andrew Howard United States 32 3.2k 1.4× 225 0.2× 294 0.4× 458 1.3× 568 1.7× 96 5.5k
Yan Guan China 34 977 0.4× 234 0.2× 648 0.8× 411 1.2× 163 0.5× 146 3.1k
Kamaljit Kaur Canada 38 2.0k 0.9× 145 0.1× 341 0.4× 785 2.2× 402 1.2× 101 3.9k
Hua Jin China 38 2.7k 1.2× 184 0.2× 179 0.2× 684 1.9× 320 0.9× 128 5.2k
Luigi Cattel Italy 37 2.9k 1.3× 194 0.2× 498 0.6× 1.0k 2.9× 909 2.7× 142 5.4k
Teruna J. Siahaan United States 39 2.8k 1.2× 159 0.1× 624 0.7× 634 1.8× 841 2.5× 199 5.8k

Countries citing papers authored by Gary W. Ashley

Since Specialization
Citations

This map shows the geographic impact of Gary W. Ashley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. Ashley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. Ashley more than expected).

Fields of papers citing papers by Gary W. Ashley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. Ashley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. Ashley. The network helps show where Gary W. Ashley may publish in the future.

Co-authorship network of co-authors of Gary W. Ashley

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. Ashley. A scholar is included among the top collaborators of Gary W. Ashley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. Ashley. Gary W. Ashley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santi, Daniel V., Gary W. Ashley, Luc Cabel, & François‐Clément Bidard. (2024). Could a Long-Acting Prodrug of SN-38 be Efficacious in Sacituzumab Govitecan-Resistant Tumors?. BioDrugs. 38(2). 171–176. 5 indexed citations
2.
Schneider, Eric L., et al.. (2024). The limitation of lipidation: Conversion of semaglutide from once-weekly to once-monthly dosing. Proceedings of the National Academy of Sciences. 121(47). e2415815121–e2415815121. 3 indexed citations
3.
Hendrickson, Andrea E. Wahner, Nathan R. Foster, Matthew S. Block, et al.. (2024). Phase II clinical trial of PLX038 in patients with platinum resistant ovarian, primary peritoneal and fallopian tube cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS5630–TPS5630. 1 indexed citations
4.
Hangasky, John A., Rodrigo Fernández, Dimitris Stellas, et al.. (2024). Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity. Frontiers in Immunology. 15. 1458145–1458145. 3 indexed citations
5.
Fontaine, Shaun D., Christopher W. Carreras, Ralph R. Reid, Gary W. Ashley, & Daniel V. Santi. (2023). A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors. Cancer Research Communications. 3(5). 908–916. 2 indexed citations
6.
Thomas, Anish, Shaun D. Fontaine, Morgan E. Diolaiti, et al.. (2022). PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM -Deficient Tumors and Potent Synergy With PARP Inhibitors. Molecular Cancer Therapeutics. 21(11). 1722–1728. 7 indexed citations
7.
Meher, Niranjan, Gary W. Ashley, Anil P. Bidkar, et al.. (2022). Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers. ACS Applied Materials & Interfaces. 14(45). 50569–50582. 19 indexed citations
8.
Fontaine, Shaun D., Gary W. Ashley, Peter J. Houghton, et al.. (2020). A Very Long-Acting PARP Inhibitor Suppresses Cancer Cell Growth in DNA Repair-Deficient Tumor Models. Cancer Research. 81(4). 1076–1086. 16 indexed citations
9.
Beckford-Vera, Denis, Shaun D. Fontaine, Henry F. VanBrocklin, et al.. (2019). PET Imaging of the EPR Effect in Tumor Xenografts Using Small 15 nm Diameter Polyethylene Glycols Labeled with Zirconium-89. Molecular Cancer Therapeutics. 19(2). 673–679. 36 indexed citations
10.
Fontaine, Shaun D., Angelo Santi, Ralph R. Reid, et al.. (2019). PLX038: a PEGylated prodrug of SN-38 independent of UGT1A1 activity. Cancer Chemotherapy and Pharmacology. 85(1). 225–229. 4 indexed citations
11.
Hearn, Brian R., Shaun D. Fontaine, Samuel J. Pfaff, et al.. (2018). Primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system. Journal of Controlled Release. 278. 74–79. 12 indexed citations
12.
Ashley, Gary W., Mark A. Burlingame, Ruchir P. Desai, et al.. (2006). Preparation of Erythromycin Analogs Having Functional Groups at C-15. The Journal of Antibiotics. 59(7). 392–401. 19 indexed citations
13.
Ashley, Gary W. & John R. Carney. (2004). API-Mass Spectrometry of Polyketides. II. Fragmentation Analysis of 6-Deoxyerythronolide B Analogs. The Journal of Antibiotics. 57(9). 579–589. 5 indexed citations
14.
Revill, W. Peter, Jan Voda, Loleta Chung, et al.. (2002). Genetically Engineered Analogs of Ascomycin for Nerve Regeneration. Journal of Pharmacology and Experimental Therapeutics. 302(3). 1278–1285. 41 indexed citations
15.
Carreras, Christopher W. & Gary W. Ashley. (2000). Manipulation of polyketide biosynthesis for new drug discovery. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 89. 89–108. 2 indexed citations
16.
MacDonald, Robert C., Gary W. Ashley, Vera A. Rakhmanova, et al.. (1999). Cationic phospholipids: physical properties, complexes with DNA and transfection activity. Cellular & Molecular Biology Letters. 4(2). 1 indexed citations
17.
MacDonald, Robert C., Gary W. Ashley, Vera A. Rakhmanova, et al.. (1999). Physical and Biological Properties of Cationic Triesters of Phosphatidylcholine. Biophysical Journal. 77(5). 2612–2629. 123 indexed citations
18.
Ashley, Gary W. & Diana M. Kushlan. (1991). Chemical synthesis of oligodeoxynucleotide dumbbells. Biochemistry. 30(11). 2927–2933. 82 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Nicotra Breakdown of academic impact, for papers by Enea Menegatti Breakdown of academic impact, for papers by Jörg Rademann Breakdown of academic impact, for papers by Keykavous Parang Breakdown of academic impact, for papers by Andrew Howard Breakdown of academic impact, for papers by Yan Guan Breakdown of academic impact, for papers by Kamaljit Kaur Breakdown of academic impact, for papers by Hua Jin Breakdown of academic impact, for papers by Luigi Cattel Breakdown of academic impact, for papers by Teruna J. Siahaan
Rankless by CCL
2026